The impact of type 2 diabetes on sex- and stage-specific melanoma recurrence and mortality: A Danish cohort study, 2004 to 2024
T2D was associated with poorer prognosis among males with localised melanoma, whereas no prognostic impact was observed among females or patients with more advanced disease. These findings indicate the need for closer follow-up of males with early-stage melanoma and T2D, and for further studies to clarify underlying mechanisms and the potential benefits of optimised diabetes management.
Authors
- Tinne Laurberg (ORCID: https://orcid.org/0000-0002-7555-2665)
- Eeva‐Liisa Røssell (ORCID: https://orcid.org/0000-0001-6423-383X)
- Jens Ejrnæs Lyngstrand (ORCID: https://orcid.org/0009-0004-0086-5650)
- Marie L Bønnelykke-Behrndtz
Institutions
- Aarhus University Hospital (DK)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2026-03-13
- DOI
- https://doi.org/10.1093/bjd/ljag097
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00